News on NeoPharm from BioPortfolio.com http://www.BioPortfolio.com Consolidated NeoPharm news from BioPortfolio.com Wed, 10 Feb 2010 06:11:26 GMT en Research and Markets: Hong Kong Pharmaceuticals and Healthcare Report Q1 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3961332&HITNO=0&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3961332&THISHREF=http://c.moreover.com/click/here.pl%3fz2496702965%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3961332&HITNO=0&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3961332&THISHREF=http://c.moreover.com/click/here.pl%3fz2496702965%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Research and Markets: Hong Kong Pharmaceuticals and Healthcare Report Q1 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960979&HITNO=1&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960979&THISHREF=http://c.moreover.com/click/here.pl%3fz2496535227%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960979&HITNO=1&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960979&THISHREF=http://c.moreover.com/click/here.pl%3fz2496535227%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Research and Markets: Hong Kong Pharmaceuticals and Healthcare Report Q1 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958131&HITNO=2&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958131&THISHREF=http://c.moreover.com/click/here.pl%3fz2495232069%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958131&HITNO=2&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958131&THISHREF=http://c.moreover.com/click/here.pl%3fz2495232069%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: NeoPharm Presents the Phase II Data of Liposome-Entrapped Paclitaxel (LEP) in Patients with Metastatic Breasthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3880938&HITNO=3&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3880938&THISHREF=http://c.moreover.com/click/here.pl%3fz2453701312%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3880938&HITNO=3&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3880938&THISHREF=http://c.moreover.com/click/here.pl%3fz2453701312%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: NeoPharm reports encouraging results from Phase II breast cancer trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3880048&HITNO=4&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3880048&THISHREF=http://c.moreover.com/click/here.pl%3fz2453148708%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3880048&HITNO=4&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3880048&THISHREF=http://c.moreover.com/click/here.pl%3fz2453148708%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: NeoPharm reports encouraging results from Phase II breast cancer trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3877437&HITNO=5&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3877437&THISHREF=http://c.moreover.com/click/here.pl%3fz2451930025%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3877437&HITNO=5&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3877437&THISHREF=http://c.moreover.com/click/here.pl%3fz2451930025%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPoten & Partners: NeoPharm Presents The Phase II Data Of Liposome-Entrapped Paclitaxel (LEP) In Patients With Metastatic Breast Cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876980&HITNO=6&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876980&THISHREF=http://c.moreover.com/click/here.pl%3fz2451753548%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876980&HITNO=6&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876980&THISHREF=http://c.moreover.com/click/here.pl%3fz2451753548%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: NeoPharm reports encouraging results from Phase II breast cancer trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3877860&HITNO=7&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3877860&THISHREF=http://c.moreover.com/click/here.pl%3fz2452081526%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3877860&HITNO=7&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3877860&THISHREF=http://c.moreover.com/click/here.pl%3fz2452081526%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Phase II clinical trial results of Liposome-Entrapped Paclitaxel announcedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3869126&HITNO=8&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3869126&THISHREF=http://c.moreover.com/click/here.pl%3fz2448129194%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3869126&HITNO=8&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3869126&THISHREF=http://c.moreover.com/click/here.pl%3fz2448129194%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: NeoPharm Files IND Application for IL13-PE38QQRhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3869055&HITNO=9&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3869055&THISHREF=http://c.moreover.com/click/here.pl%3fz2448078720%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3869055&HITNO=9&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3869055&THISHREF=http://c.moreover.com/click/here.pl%3fz2448078720%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: NeoPharm Files IND Application for IL13-PE38QQRhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3869048&HITNO=10&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3869048&THISHREF=http://c.moreover.com/click/here.pl%3fz2448078385%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3869048&HITNO=10&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3869048&THISHREF=http://c.moreover.com/click/here.pl%3fz2448078385%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: NeoPharm Presents the Phase II Data of Liposome-Entrapped Paclitaxel (LEP) in Patients with Metastatic Breast Cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3864784&HITNO=11&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3864784&THISHREF=http://c.moreover.com/click/here.pl%3fz2446109826%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3864784&HITNO=11&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3864784&THISHREF=http://c.moreover.com/click/here.pl%3fz2446109826%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: NeoPharm Presents the Phase II Data of Liposome-Entrapped Paclitaxel (LEP) in Patients with Metastatic Breasthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3865233&HITNO=12&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3865233&THISHREF=http://c.moreover.com/click/here.pl%3fz2446249490%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3865233&HITNO=12&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3865233&THISHREF=http://c.moreover.com/click/here.pl%3fz2446249490%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: NeoPharm Announces IND Filing For IL13-PE38QQR For The Treatment Of Idiopathic Pulmonary Fibrosishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3862588&HITNO=13&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3862588&THISHREF=http://c.moreover.com/click/here.pl%3fz2445081681%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3862588&HITNO=13&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3862588&THISHREF=http://c.moreover.com/click/here.pl%3fz2445081681%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMediLexicon: NeoPharm seeks US FDA nod for IL13-PE38QQR to treat Idiopathic Pulmonary Fibrosishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3863723&HITNO=14&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3863723&THISHREF=http://c.moreover.com/click/here.pl%3fz2445699224%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3863723&HITNO=14&MSIZE=37&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NeoPharm&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3863723&THISHREF=http://c.moreover.com/click/here.pl%3fz2445699224%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: